Speculation arises regarding reports that the Omicron variant may have originated in an untreated HIV patient. This is linked to the fact that Pfizer’s new COVID-19 therapeutic pill utilizes a protease inhibitor commonly used in HIV treatments.
3 chapters across the catalog
Speculation arises regarding reports that the Omicron variant may have originated in an untreated HIV patient. This is linked to the fact that Pfizer’s new COVID-19 therapeutic pill utilizes a protease inhibitor commonly used in HIV treatments.
Pfizer Paxlovid, HIV Drug Integration, Dutch Regulators
Dutch regulators have raised concerns about the marketing of Pfizer’s COVID-19 pill, Paxlovid, on public television. The medication combines an investigational antiviral with Ritonavir, a drug traditionally used to treat HIV. Pfizer claims the treatment reduces hospitalization risk by 89% if administered within three days of symptom onset.
Magic Johnson, Pfizer COVID Pill, HIV Drug Combinations
Pfizer announced a new antiviral COVID-19 pill that utilizes a combination with the widely used HIV drug Ritonavir. Former NBA player Magic Johnson appeared in media interviews discussing his long-term HIV protocol and the need for drugs to prolong life, which is interpreted as a marketing effort to normalize daily antiviral "cocktails." The discussion suggests these treatments may be positioned to address autoimmune issues allegedly arising from vaccine breakthrough cases.